Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients.

Venken T, Miller IS, Arijs I, Thomas V, Barat A, Betge J, Zhan T, Gaiser T, Ebert MP, O'Farrell AC, Prehn J, Klinger R, O'Connor DP, Moulton B, Murphy V, Serna G, Nuciforo PG, McDermott R, Bird B, Leonard G, Grogan L, Horgan A, Schulte N, Moehler M, Lambrechts D, Byrne AT.

Open source

DOI: 10.1038/s41525-024-00415-x
Published: 2024-05-29
Container: NPJ Genom Med
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41525-024-00415-x,
  title = {Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients.},
  author = {Venken T and  Miller IS and  Arijs I and  Thomas V and  Barat A and  Betge J and  Zhan T and  Gaiser T and  Ebert MP and  O'Farrell AC and  Prehn J and  Klinger R and  O'Connor DP and  Moulton B and  Murphy V and  Serna G and  Nuciforo PG and  McDermott R and  Bird B and  Leonard G and  Grogan L and  Horgan A and  Schulte N and  Moehler M and  Lambrechts D and  Byrne AT.},
  year = {2024},
  journal = {NPJ Genom Med},
  doi = {10.1038/s41525-024-00415-x},
  url = {https://doi.org/10.1038/s41525-024-00415-x}
}

RIS

TY  - JOUR
TI  - Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients.
AU  - Venken T
AU  -  Miller IS
AU  -  Arijs I
AU  -  Thomas V
AU  -  Barat A
AU  -  Betge J
AU  -  Zhan T
AU  -  Gaiser T
AU  -  Ebert MP
AU  -  O'Farrell AC
AU  -  Prehn J
AU  -  Klinger R
AU  -  O'Connor DP
AU  -  Moulton B
AU  -  Murphy V
AU  -  Serna G
AU  -  Nuciforo PG
AU  -  McDermott R
AU  -  Bird B
AU  -  Leonard G
AU  -  Grogan L
AU  -  Horgan A
AU  -  Schulte N
AU  -  Moehler M
AU  -  Lambrechts D
AU  -  Byrne AT.
PY  - 2024
JO  - NPJ Genom Med
DO  - 10.1038/s41525-024-00415-x
UR  - https://doi.org/10.1038/s41525-024-00415-x
ER  -

APA

T, V., IS, M., I, A., V, T., A, B., J, B., T, Z., T, G., MP, E., AC, O., J, P., R, K., DP, O., B, M., V, M., G, S., PG, N., R, M., B, B., G, L., L, G., A, H., N, S., M, M., D, L., & AT., B. (2024). Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients.. NPJ Genom Med. https://doi.org/10.1038/s41525-024-00415-x

Source records

europe-pmc · retrieved 2026-09-26T06:27:29.958Z
doaj · retrieved 2026-09-26T06:27:29.944Z